Diagnostics

RSS

NeuraCeq obtains E.U. approval for PET imaging of beta-amyloid neuritic plaque density

Feb. 25, 2014

Supplemental NDA for Lymphoseek granted priority review by FDA

Feb. 19, 2014

Millennium Pharmaceuticals to conduct PET imaging study of [68Ga]MLN-6907

Feb. 17, 2014

Antibody DNA barcoding used for protein analysis of fine-needle aspirates

Feb. 13, 2014

Novelos Therapeutics changes name

Feb. 12, 2014

Technetium Tc 99m trofolastat accurately detects cancer in the prostate gland

Feb. 11, 2014

Navidea reports initial results from phase IIb trial of its beta-amyloid imaging agent NAV-4694

Feb. 7, 2014

bioTheranostics launches suite of genomic-based tests

Feb. 5, 2014

Radiotracer [18F]VM-4-037 evaluated in phase II renal cancer study

Feb. 3, 2014

Amarantus and Boston University to evaluate test for early signs of neurodegenerative diseases

Jan. 31, 2014